Criteria for the Diagnosis of Lupus Anticoagulants: An Update: On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH

Antiphospholipid Antibodies and Coagulation Regulatory Protein Abnormalities in Children with Pulmonary Emboli

Nuss, R., Hays, T., Chudgar, U., et al. (1997) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199705000-00005 · Cited by 31

Lupus anticoagulant-hypoprothrombinemia syndrome and similar diseases: experiences at a single center in Japan

Ieko, M., Yoshida, M., Naito, S., et al. (2019) · International Journal of Hematology · doi:10.1007/s12185-019-02674-2 · Cited by 30

Validation of a commercially available kit to detect anti-phosphatidylserine/prothrombin antibodies in a cohort of systemic lupus erythematosus patients

Sciascia, S., Sanna, G., Murru, V., Khamashta, M. A., & Bertolaccini, M. L. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.12.001 · Cited by 30

Antiphospholipid Syndrome and Vascular Ischemic (Occlusive) Diseases: An Overview

Atanassova, P. A. (2007) · Yonsei Medical Journal · doi:10.3349/ymj.2007.48.6.901 · Cited by 31

Cognitive dysfunction and white matter abnormalities in antiphospholipid syndrome

Erkan, D., Kozora, E., & Lockshin, M. D. (2010) · Pathophysiology · doi:10.1016/j.pathophys.2010.04.010 · Cited by 30

Symptomatic polyautoimmunity at diagnosis of 1463 childhood-onset lupus: A Brazilian multicenter study

Setoue, D. N. D., Pitta, A. C., Fiorot, F. J., Nastri, M. M. F., Novak, G. V., Molinari, B. C., OLIVEIRA, J. C. D., Gormezano, N. W. S., Sakamoto, A. P., Terreri, M. T., et al. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.03.009 · Cited by 30

Conceptions and Misconceptions in Testing for Lupus Anticoagulants

Exner, T. (2000) · Journal of Autoimmunity · doi:10.1006/jaut.2000.0392 · Cited by 30

Catastrophic haemorrhage in a case of paediatric primary antiphospholipid syndrome and factor II deficiency

Hudson, N., Duffy, C., Rauch, J., et al. (1997) · Lupus · doi:10.1177/096120339700600110 · Cited by 30

Disease modifying treatment and elective surgery in rheumatoid arthritis: the need for more data

Jain, A., Maini, R., & Nanchahal, J. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.017640 · Cited by 30

Thrombotic events during long-term follow-up of obstetric antiphospholipid syndrome patients

Lefèvre, G., Lambert, M., Bacri, J.-L., Dubucquoi, S., Quéméneur, T., Caron, C., Launay, D., Houfflin‐Debarge, V., HACHULLA, E., Kyndt, X., et al. (2011) · Lupus · doi:10.1177/0961203310397080 · Cited by 29

Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA)

Pengo, V., Denas, G., Bison, E., Banzato, A., Jose, S. P., Gresele, P., Marongiu, F., Erba, N., Veschi, F., Ghirarduzzi, A., et al. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2010.05.018 · Cited by 29

A new chromogenic assay (HemosIL ThromboPath) is sensitive to major prothrombotic risk factors affecting the protein C pathway. Results of a multicenter study

Toulon, P. A., Smirnov, M. D., Triscott, M., et al. (2009) · Thrombosis Research · doi:10.1016/j.thromres.2008.11.017 · Cited by 29

Lymphocyte Disturbances in Primary Antiphospholipid Syndrome and Application to Venous Thromboembolism Follow-Up

Simonin, L., Pasquier, É., Leroyer, C., Cornec, D., Lemerle, J., Bendaoud, B., Hillion, S., Pers, J., Couturaud, F., & Renaudineau, Y. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-016-8568-1 · Cited by 29

Monitoring patients with the lupus anticoagulant while treated with vitamin K antagonists: communication from the SSC of the ISTH

Tripodi, A., de Laat, B., Wahl, D. G., Ageno, W., Cosmi, B., & Crowther, M. A. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13481 · Cited by 30

Retinal vasculopathy in patients with systemic lupus erythematosus

Gao, N., Li, M. T., Li, Y., et al. (2017) · Lupus · doi:10.1177/0961203317698050 · Cited by 29

Interference of DOACs in different DRVVT assays for diagnosis of lupus anticoagulants

Flieder, T., Weiser, M., Eller, T., Dittrich, M. T., von Bargen, K., Alban, S., Kühn, J., Knabbe, C., & Birschmann, I. (2018) · Thrombosis Research · doi:10.1016/j.thromres.2018.03.009 · Cited by 29

High risk of adverse pregnancy outcomes in women with a persistent lupus anticoagulant

Gebhart, J., Posch, F., Koder, S., Quehenberger, P., Perkmann, T., Kuessel, L., Ay, C., & Pabinger, I. (2019) · Blood Advances · doi:10.1182/bloodadvances.2018026948 · Cited by 29

Myocardial infarction in young patients without coronary atherosclerosis: assume primary antiphospholipid syndrome until proved otherwise

Davies, J. O. J., & Hunt, B. J. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.01245.x · Cited by 29

Lupus Anticoagulants Form Immune Complexes With Prothrombin and Phospholipid That Can Augment Thrombin Production in Flow

Field, S. L., Hogg, P. J., Daly, E. B., Dai, Y., Murray, B., Owens, D., & Chesterman, C. N. (1999) · Blood · doi:10.1182/blood.v94.10.3421.422k27_3421_3431 · Cited by 29

Clinical characteristics and laboratory findings of 252 Chinese patients with anti-phospholipid syndrome: comparison with Euro-Phospholipid cohort

Shi, H., Teng, J., Sun, Y., Wu, X., Hu, Q., Liu, H.-L., Cheng, X., Yin, Y., Ye, J., Chen, P. P., et al. (2017) · Clinical Rheumatology · doi:10.1007/s10067-017-3549-1 · Cited by 28

Antiphospholipid syndrome, “the best prophet of the future”

Amengual, O., & Atsumi, T. (2018) · Modern Rheumatology · doi:10.1080/14397595.2018.1435988 · Cited by 30

Angiogenic factors in pregnancies of women with antiphospholipid syndrome and systemic lupus erythematosus

Mayer-Pickel, K. I., Stern, C., Eberhard, K., Lang, U., Obermayer-Pietsch, B. M., & Cervar-Zivkovic, M. (2018) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2018.04.002 · Cited by 28

Primary antiphospholipid syndrome in Latin American mestizo patients: clinical and immunologic characteristics and comparison with European patients

Mejía-Romero, R. A., García‐Carrasco, M., Galarza-Maldonado, C. M., Santos, P., Pinto, C. M., Escarcega, R. O., Salinas-Saldivar, S., Soto-Vega, E. N., López‐Colombo, A., & Cervera, R. (2007) · Clinical Rheumatology · doi:10.1007/s10067-007-0818-4 · Cited by 29

Damage did not independently influence mortality in childhood systemic lupus erythematosus

Appenzeller, S., Marini, R., & Costallat, L. T. (2005) · Rheumatology International · doi:10.1007/s00296-004-0552-z · Cited by 28

American Society for Reproductive Immunology Report of the Committee for Establishing Criteria for Diagnosis of Reproductive Autoimmune Syndrome

Coulam, C. B., Branch, D. W., Clark, D. A., et al. (1999) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.1999.tb00086.x · Cited by 28

Antiprothombin antibodies and the diagnosis of antiphospholipid syndrome

Amengual, O., Atsumi, T., & Koike, T. (2004) · Clinical Immunology · doi:10.1016/j.clim.2004.02.013 · Cited by 28

Neurological manifestations of the antiphospholipid syndrome: risk assessments and evidence-based medicine

Muscal, E., & Brey, R. L. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01478.x · Cited by 25

The clinical relevance of the IgM isotype of antiphospholipid antibodies in the vascular antiphospholipid syndrome

Del Ross, T., Ruffatti, A., Cuffaro, S., Tonello, M., Calligaro, A., Favaro, M., Facchinetti, M., Hoxha, A., & Punzi, L. (2015) · Thrombosis Research · doi:10.1016/j.thromres.2015.08.019 · Cited by 27

Circulating Immune Complexes of IgA Bound to Beta 2 Glycoprotein are Strongly Associated with the Occurrence of Acute Thrombotic Events

Martínez-Flores, J. A., Serrano, M., Pérez, M. D., de la Cámara, A. G., Lora, D., Morillas, L., Ayala, R. M., Paz‐Artal, E., Morales, J. M., & Serrano, A. (2016) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.34488 · Cited by 26

Clinical and immunological features of antiphospholipid syndrome in the elderly: a retrospective national multicentre study

Grimaud, F., Yelnik, C., de Chambrun, M. P., Amoura, Z., Arnaud, L., Costedoat-Chalumeau, N., HACHULLA, E., Lambert, M., Roriz, M., Sibilia, J., et al. (2018) · Lara D. Veeken · doi:10.1093/rheumatology/key437 · Cited by 27

Altered platelet proteome in lupus anticoagulant (LA)-positive patients—protein disulfide isomerase and NETosis as new players in LA-related thrombosis

Hell, L., Lurger, K., Mauracher, L., Grilz, E., Reumiller, C. M., Schmidt, G. J., Ercan, H., Koder, S., Assinger, A., Basílio, J., et al. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0358-4 · Cited by 27

Increased serum levels of soluble l -selectin (CD62L) in patients with active systemic lupus erythematosus (SLE)

Font, J., Pizcueta, P., Ramos‐Casals, M., et al. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01082.x · Cited by 27

Lupus Anticoagulant Induced by the Combination of Valproate and Lamotrigine

Echaniz‐Laguna, A., Thiriaux, A., Ruolt‐Olivesi, I., et al. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb02054.x · Cited by 27

Lupus Anticoagulant Measurement

Mackie, I. J., Donohoe, S., & Machin, S. J. (2000) · Springer eBooks · doi:10.1007/978-1-4471-3666-8_22 · Cited by 27

Cooperation experience in a multicentre study to define the upper limits in a normal population for the diagnostic assessment of the functional lupus anticoagulant assays

Pradella, P., Azzarini, G., Santarossa, L., Caberlotto, L., Bardin, C., Poz, A., D’Aurizio, F., & Giacomello, R. (2013) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2012-0382 · Cited by 26

MR imaging findings suggestive of posterior reversible encephalopathy syndrome in adolescents with systemic lupus erythematosus

Muscal, E., Traipe, E., de Guzman, M. M., et al. (2010) · Pediatric Radiology · doi:10.1007/s00247-009-1540-y · Cited by 26

The incidence and prevalence of systemic lupus erythematosus in Thrace, 2003–2014: A 12-year epidemiological study

Pamuk, Ö. N., Balcı, M., Dönmez, S., et al. (2015) · Lupus · doi:10.1177/0961203315603141 · Cited by 26

Role of thrombophilic factors in full-term infants with neonatal encephalopathy

Harteman, J. C., Groenendaal, F., Benders, M. J. N. L., Huisman, A., Blom, H. J., & de Vries, L. S. (2012) · Pediatric Research · doi:10.1038/pr.2012.150 · Cited by 26

Homocysteine, antiphospholipid antibodies and risk of thrombosis in patients with systemic lupus erythematosus

Martínez-Berriotxoa, A., Ruiz‐Irastorza, G., Egurbide, M.-V., Rueda, M., & Aguirre, C. (2004) · Lupus · doi:10.1191/0961203304lu2035oa · Cited by 26

Antibodies to tissue‐type plasminogen activator (t‐PA) in patients with inflammatory bowel disease: high prevalence, interactions with functional domains of t‐PA and possible implications in thrombosis

Saibeni, S., Ciscato, C., Vecchi, M. L., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01970.x · Cited by 26

Antiphospholipid Antibody Testing: Which Are Most Useful for Diagnosis?

Bertolaccini, M. L., & Hughes, G. R. V. (2006) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2006.05.001 · Cited by 26

Thrombophilia and Stroke

Green, D. (2003) · Topics in Stroke Rehabilitation · doi:10.1310/l9kd-n5n8-69x0-08qk · Cited by 26

Antiphospholipid antibody syndrome: Rapid, sensitive, and specific flow cytometric assay for determination of anti-platelet phospholipid autoantibodies

Tomer, A. (2002) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2002.121551 · Cited by 26

Cardiovascular risk factors are major determinants of thrombotic risk in patients with the lupus anticoagulant

Posch, F., Gebhart, J., Rand, J. H., Koder, S., Quehenberger, P., Pengo, V., Ay, C., & Pabinger, I. (2017) · BMC Medicine · doi:10.1186/s12916-017-0807-7 · Cited by 25

Clinical significance and correlations between anti-β2 glycoprotein I IgA assays in antiphospholipid syndrome and/or systemic lupus erythematosus

Tebo, A. E., Willis, R., Jaskowski, T. D., Guerra, M. M., Pierangeli, S. S., Salmon, J. E., Petri, M., & Branch, D. W. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.06.025 · Cited by 25

Serum interleukin-17 levels are associated with nephritis in childhood-onset systemic lupus erythematosus

Peliçari, K. D. O., Postal, M., Sinicato, N. A., Peres, F. A., Fernandes, P. T., Marini, R., Costallat, L. T. L., & Appenzeller, S. (2015) · Clinics · doi:10.6061/clinics/2015(05)01 · Cited by 26

Presence of low titre of antiphospholipid antibodies in cancer patients: a prospective study

Bazzan, M., Montaruli, B., Vaccarino, A., et al. (2009) · Internal and Emergency Medicine · doi:10.1007/s11739-009-0316-6 · Cited by 25

Modified phosphatidylserine-dependent antithrombin ELISA enables identification of patients negative for other antiphospholipid antibodies and also detects low avidity antibodies

Žigon, P., Ambrožič, A., Čučnik, S., Kveder, T., Rozman, B., & Božič, B. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.162 · Cited by 25

TNFA Gene Promoter Polymorphisms and Susceptibility to Recurrent Pregnancy Loss in Italian Women

Palmirotta, R., Farina, F. L., Ferroni, P., et al. (2010) · Reproductive Sciences · doi:10.1177/1933719110366603 · Cited by 25

Aspirin Desensitization in the Treatment of Antiphospholipid Syndrome during Pregnancy in ASA‐sensitive Patients

Alijotas‐Reig, J., Miguel-Moncı́n, M. S., & Cisteró‐Bahíma, A. (2005) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2005.00322.x · Cited by 25

Reduction of Cerebral and Corpus Callosum Volumes in Childhood‐Onset Systemic Lupus Erythematosus: A Volumetric Magnetic Resonance Imaging Analysis

Lapa, A. T., Postal, M., Sinicato, N. A., Ferreira, W. G., Bellini, B. S., Fernandes, P. T., Rittner, L., Marini, R., Cendes, F., & Appenzeller, S. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39680 · Cited by 25

Long-term effect of B-cells depletion alone as rescue therapy for severe thrombocytopenia in primary antiphospholipid syndrome

Sciascia, S., Radin, M., Cecchi, I., Rubini, E., Bazzan, M., & Roccatello, D. (2018) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2018.04.001 · Cited by 25

Antiphospholipid antibody syndrome: the flow cytometric annexin A5 competition assay as a diagnostic tool

Tomer, A., Bar-Lev, S., Fleisher, S., Shenkman, B., Friger, M. D., & Abu‐Shakra, M. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06751.x · Cited by 25

High titres of IgM-antiphospholipid antibodies are unrelated to pathogenicity in patients with non-Hodgkin’s lymphoma

Miesbach, W., Scharrer, I., & Asherson, R. A. (2006) · Clinical Rheumatology · doi:10.1007/s10067-006-0328-9 · Cited by 25

Occurrence of anti-prothrombin and anti-β2- glycoprotein I antibodies in patients with history of thrombosis

Forastiero, R. R., Martinuzzo, M. E., Adamczuk, Y., & Carreras, L. O. (1999) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(99)90101-4 · Cited by 25

Autoimmune disease as a cause of reproductive failure

Rote, N. S., & Stetzer, B. P. (2003) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(03)00022-2 · Cited by 26

Antiphospholipid antibodies in patients with autoimmune blistering disease

Echigo, T., Hasegawa, M., Inaoki, M., Yamazaki, M., Sato, S., & Takehara, K. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.07.004 · Cited by 25

Tests for lupus anticoagulant revisited

Derksen, R. H. W. M., & de Groot, P. G. (2004) · Thrombosis Research · doi:10.1016/j.thromres.2004.06.009 · Cited by 27

LDLR and PCSK9 Are Associated with the Presence of Antiphospholipid Antibodies and the Development of Thrombosis in aPLA Carriers

Ochoa, E., Iriondo, M., Manzano, C., Fullaondo, A., Villar, I., Ruiz‐Irastorza, G., Zubiaga, A. M., & Estonba, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146990 · Cited by 24

Acquired and Inherited Thrombophilia Disorders in Pregnancy

Pierangeli, S. S., Leader, B., Barilaro, G., Willis, R., & Branch, D. W. (2011) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2011.02.016 · Cited by 25

Influence of antiphospholipid antibody levels and type on thrombotic manifestations: results from the Serbian National Cohort Study

Stojanovich, L., Marković, O., Marisavljević, D., Elezović, I. V., Ilijevski, N. S., & Stanisavljević, N. (2011) · Lupus · doi:10.1177/0961203311422710 · Cited by 24

Evaluation of novel assays for the detection of autoantibodies in antiphospholipid syndrome

Sciascia, S., Radin, M., Ramirez, C., Seaman, A., Bentow, C., Casas, S., Cecchi, I., Rubini, E., Foddai, S. G., Baldovino, S., et al. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102641 · Cited by 24

Identification of Thrombin Antibodies in Patients with Antiphospholipid Syndrome

Miesbach, W., Matthias, T., & Scharrer, I. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1313.026 · Cited by 24

Increased Expression of Phospholipid Scramblase 1 in Monocytes from Patients with Systemic Lupus Erythematosus

SUZUKI, E., Amengual, O., Atsumi, T., et al. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.091420 · Cited by 24

False negative screening tests for lupus anticoagulants—An unrecognized problem?

Jacobsen, E. M., & Wislöff, F. (1996) · Thrombosis Research · doi:10.1016/0049-3848(96)00094-1 · Cited by 24

Antiphospholipid Syndrome: Association Between Laboratory Tests and Clinical Practice

Galli, M. (2003) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000083810 · Cited by 23

Increased CD11b neutrophil expression in Budd–Chiari syndrome or portal vein thrombosis secondary to polycythaemia vera

Álvarez‐Larrán, A., García‐Pagán, J. C., Abraldeṣ, J. G., et al. (2004) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04770.x · Cited by 24

Increased lipid peroxidation correlates with platelet activation but not with markers of endothelial cell and blood coagulation activation in patients with antiphospholipid antibodies

Martinuzzo, M. E., Forastiero, R. R., Kordich, L., et al. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03028.x · Cited by 24

The impact of the search for thrombophilia risk factors among antiphospholipid syndrome patients with thrombosis

Torresan, M., Machado, T. F. G. S., Siqueira, L. H., et al. (2000) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-200010000-00014 · Cited by 24

Comparison of thrombotic risk between 85 homozygotes and 481 heterozygotes carriers of the factor V Leiden mutation: retrospective analysis from the Procare Study

The Procare Group (2000) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-200009000-00002 · Cited by 24

ISTH/SSC lupus anticoagulant testing guidelines: how far have these been adopted by laboratories?

Jennings, I., KITCHEN, S., Kitchen, D. P., WOODS, T. A. L., & Walker, I. D. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04448.x · Cited by 22

Predictive role of hs-C-reactive protein in patients with antiphospholipid syndrome

Miesbach, W., Gökpinar, B., Gilzinger, A., et al. (2005) · Immunobiology · doi:10.1016/j.imbio.2005.10.006 · Cited by 23

Clinical Importance of Positive Test Results for Lupus Anticoagulant and Anticardiolipin Antibodies

Prøven, A., Bartlett, R. P., Moder, K. G., Chang‐Miller, A., Cardel, L. K., Heit, J. A., Homburger, H. A., Petterson, T. M., Christianson, T. J. H., & Nichols, W. L. (2004) · Mayo Clinic Proceedings · doi:10.4065/79.4.467 · Cited by 23

Pregnancy outcome after a first episode of cerebral vein thrombosis

Martinelli, I., Passamonti, S. M., Maino, A., et al. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13496 · Cited by 23

Dilute prothrombin time-based lupus ratio test

Liestøl, S., Jacobsen, E. M., & Wislöff, F. (2002) · Thrombosis Research · doi:10.1016/s0049-3848(01)00420-0 · Cited by 23

Elevated plasma levels of factor VIII in women with early recurrent miscarriage

Marietta, M., Facchinetti, F., Sgarbi, L., Simoni, L., Bertesi, M., Torelli, G., & Volpe, A. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2003.00496.x · Cited by 23

Antiphospholipid antibodies and thrombosis: do test patterns identify the patients' risk?

Galli, M. (2004) · Thrombosis Research · doi:10.1016/j.thromres.2004.08.009 · Cited by 22

Antiphospholipid Antibodies: A New Risk Factor for Restenosis After Percutaneous Transluminal Coronary Angioplasty?

Ludia, C., Domenico, P., Monia, C., et al. (1998) · Autoimmunity · doi:10.3109/08916939809003861 · Cited by 23

VENOUS THROMBOEMBOLISM IN THAI CHILDREN

Sirachainan, N., Chuansumrit, A., Angchaisuksiri, P., et al. (2007) · Pediatric Hematology and Oncology · doi:10.1080/08880010701360767 · Cited by 22

Pulmonary hypertension in systemic lupus erythematosus: echocardiography-based definitions predict 6-year survival

Hübbe‐Tena, C., Gallegos‐Nava, S., Márquez-Velasco, R., et al. (2014) · Lara D. Veeken · doi:10.1093/rheumatology/keu012 · Cited by 22

Recent advances in the antiphospholipid antibody syndrome

Chaturvedi, S., & McCrae, K. R. (2014) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000067 · Cited by 22

Clinical significance of the mixing test in laboratory diagnoses of lupus anticoagulant

Hong, S. K., Hwang, S. M., Kim, J.-E., & Kim, H. K. (2012) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e328358e899 · Cited by 22

Anti-ribosomal P antibody: a multicenter study in childhood-onset systemic lupus erythematosus patients

Valões, C. C. D. M., Molinari, B. C., Pitta, A. C., et al. (2017) · Lupus · doi:10.1177/0961203316676386 · Cited by 22

How to Identify High-Risk APS Patients: Clinical Utility and Predictive Values of Validated Scores

Oku, K., Amengual, O., Yasuda, S., & Atsumi, T. (2017) · Current Rheumatology Reports · doi:10.1007/s11926-017-0674-4 · Cited by 22

Diffuse alveolar hemorrhage in childhood-onset systemic lupus erythematosus: a severe disease flare with serious outcome

Brazilian Childhood-onset Systemic Lupus Erythematosus Group, Blay, G., Rodrigues, J. C., Ferreira, J. C. D. O. A., Leal, G. N., Gormezano, N. W. S., Novak, G. V., Pereira, R. M. R., Terreri, M. T., Magalhães, C. S., et al. (2018) · Revista Brasileira de Reumatologia · doi:10.1186/s42358-018-0038-4 · Cited by 22

The Antiphospholipid Syndrome: What are We Really Measuring? How do We Measure it? And How do We Treat it?

Ortel, T. L. (2006) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-006-5581-x · Cited by 22

Prevalence and clinical usefulness of antiphospholipid and anticofactor antibodies in different Spanish preeclampsia subsets

Ferrer‐Oliveras, R., Llurba, E., Cabero, L., et al. (2011) · Lupus · doi:10.1177/0961203311425520 · Cited by 22

Antiphospholipid antibodies are common in patients referred for percutaneous patent foramen ovale closure

Dodge, S. M., Hassell, K. L., Anderson, C. A., et al. (2003) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.10754 · Cited by 22

Usefulness of glycosylated ferritin in atypical presentations of adult onset Still's disease

Hamidou, M. A., Denis, M., Barbarot, S., Boutoille, D., Belizna, C. C., & Moël, G. L. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.012484 · Cited by 22

Relationship between Thrombophilic Disorders and Type of Severe Early-Onset Hypertensive Disorder of Pregnancy

Ganzevoort, W., Rep, A., de Vries, J. I. P., Bonsel, G. J., Wolf, H., & for the PETRA-Investigators (2007) · Hypertension in Pregnancy · doi:10.1080/10641950701521601 · Cited by 22

The Evaluation of Clotting Times in the Laboratory Detection of Lupus Anticoagulants

Jacobsen, E. M., Barna, L. K., Taylor, J., Triplett, D. A., & Wislöff, F. (2001) · Thrombosis Research · doi:10.1016/s0049-3848(01)00365-6 · Cited by 22

Testing for the lupus anticoagulant: the good, the bad, and the ugly

Favaloro, E. J., Pasalic, L., & Selby, R. (2024) · Research and Practice in Thrombosis and Haemostasis · doi:10.1016/j.rpth.2024.102385 · Cited by 25

Inherited Thrombophilia is Associated With Pregnancy Losses That Occur After 12th Gestational Week in Serbian Population

Mitic, G. P., Kovac, M. K., Považan, L., et al. (2009) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029609335518 · Cited by 21

In ECAT veritas?

Reber, G., & Meijer, P. (2012) · Lupus · doi:10.1177/0961203312446389 · Cited by 21

Anti-annexin A5 antibodies in women with spontaneous pregnancy loss

Alijotas‐Reig, J., Ferrer‐Oliveras, R., Rodrigo-Anoro, M. J., Farrán-Codina, I., Llurba, E., Vilardell, M., & Casellas‐Caro, M. (2009) · Medicina Clínica · doi:10.1016/j.medcli.2009.09.040 · Cited by 21

Characterization of antiphospholipid antibodies in chronic hepatitis B infection

Huh, J. Y., Yi, D. Y., Hwang, S. G., et al. (2011) · The Korean Journal of Hematology · doi:10.5045/kjh.2011.46.1.36 · Cited by 21

Laboratory diagnostic outcome applying detection criteria recommended by the Scientific and Standardization Committee of the ISTH on Lupus Anticoagulant

Biguzzi, E., Asti, D., Palmucci, C., Tripodi, A., & Chantarangkul, V. (2013) · Thrombosis and Haemostasis · doi:10.1160/th12-11-0850 · Cited by 21

Use of fondaparinux in a patient with antiphospholipid antibody syndrome and heparin‐associated thrombocytopenia

Holtan, S. G., Knox, S. K., & Tefferi, A. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01961.x · Cited by 21

Haemorrhagic myositis associated with prophylactic heparin use in dermatomyositis

Langguth, D., Wong, R. C. W., Archibald, C., et al. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.010272 · Cited by 21

Further evidence of false negative screening for lupus anticoagulants

Moore, G. W., Henley, A., Greenwood, C. K., & Rangarajan, S. (2007) · Thrombosis Research · doi:10.1016/j.thromres.2007.05.018 · Cited by 21

Assays for Measuring Rivaroxaban: Their Suitability and Limitations

Lindhoff‐Last, E., Samama, M. M., Ortel, T. L., Weitz, J. I., & Spiro, T. E. (2010) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e3181f2f264 · Cited by 157

Rivaroxaban for Thromboprophylaxis in Patients with Antiphospholipid Syndrome

Park, J. H., Song, J. S., & Choi, S. T. (2017) · Journal of Rheumatic Diseases · doi:10.4078/jrd.2017.24.2.108 · Cited by 1

Developing Deep Venous Thrombosis while on Rivaroxaban: A Review of Rivaroxaban

Al-Khafaji, R. A. (2020) · Clinical Case Reports · doi:10.37421/jccr.2020.10.1365 · Cited by 1

Can an anti-Xa assay for low-molecular-weight heparin be used to assess the presence of rivaroxaban?

Yates, S. G., Smith, S., Tharpe, W., Shen, Y.-M., & Sarode, R. (2016) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2016.06.005 · Cited by 18

Antiphospholipid and Thrombosis Syndromes

Bick, R. L., & Baker, W. (1994) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-1001885 · Cited by 57